ABTECo — Aqua Bio Technology ASA Balance Sheet
0.000.00%
- NOK68.29m
- NOK180.74m
- NOK106.56m
Annual balance sheet for Aqua Bio Technology ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5.43 | 13.4 | 1.86 | 5.02 | 17.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.205 | 2.81 | 2.6 | 19.9 | 14.9 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6.44 | 21.9 | 12.8 | 48.8 | 37.6 |
| Net Property, Plant And Equipment | 0.528 | 0.287 | 0.265 | 17.2 | 43.2 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 16.2 | 34.4 | 67.2 | 238 | 250 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.33 | 12.1 | 24.8 | 120 | 199 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 7.92 | 15.7 | 65.3 | 152 | 331 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 8.32 | 18.7 | 1.86 | 85.8 | -81.7 |
| Total Liabilities & Shareholders' Equity | 16.2 | 34.4 | 67.2 | 238 | 250 |
| Total Common Shares Outstanding |